Related Experiment Video
Updated: Aug 25, 2026

Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography
Published on: September 14, 2012
Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans
H M Omar Farouque1, Stephen G Worthley, Ian T Meredith
1Cardiovascular Research Centre, Monash Medical Centre and Monash University, Melbourne, Australia.
Insights
ATP-sensitive potassium (K(ATP)) channels regulate coronary blood flow. Inhibiting these channels reduced metabolic vasodilation in human coronary arteries, indicating their role in hyperemia.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Potassium Channel Function
Background:
- ATP-sensitive potassium (K(ATP)) channels are known to influence coronary blood flow (CBF).
- The specific role of K(ATP) channels in human coronary metabolic vasodilation remains unclear.
Purpose of the Study:
- To investigate the contribution of vascular K(ATP) channels to human coronary metabolic vasodilation.
- To assess the effect of K(ATP) channel inhibition on coronary hemodynamics during metabolic stimulation.
Main Methods:
- Seventeen patients underwent assessment of coronary hemodynamics.
- K(ATP) channels were inhibited using intracoronary glibenclamide.
- Metabolic vasodilation was induced by rapid right ventricular pacing, with coronary blood velocity measured by Doppler guidewire.
Main Results:
- Glibenclamide reduced resting coronary blood flow and increased resting coronary vascular resistance.
- K(ATP) channel inhibition significantly blunted pacing-induced hyperemia, reducing peak CBF and increasing minimum CVR.
- The total hyperemic volume, estimated by the area under the flow-versus-time curve, was also reduced by glibenclamide.
Conclusions:
- Vascular K(ATP) channels play a significant role in the regulation of human coronary blood flow.
- These channels are involved in the functional coronary hyperemia response following metabolic stimulation.
Objective:
Experimental evidence indicates that ATP-sensitive potassium (K(ATP)) channels regulate coronary blood flow (CBF). However, their contribution to human coronary metabolic vasodilation is unknown.
Methods And Results:
Seventeen patients (12 male, age 58+/-10 years) were studied. Coronary hemodynamics were assessed before and after K(ATP) channel inhibition with subselective intracoronary glibenclamide infused at 40 microg/min in an angiographically smooth coronary artery after successful percutaneous coronary intervention to another vessel. Metabolic vasodilation was induced by 2 minutes of rapid right ventricular pacing. Coronary blood velocity was measured with a Doppler guidewire and CBF calculated. The time course of hyperemia was recorded for 2 minutes after pacing, and hyperemic volume was estimated from the area under the flow-versus-time curve (AUC). Compared with vehicle infusion (0.9% saline), glibenclamide reduced resting CBF by 9% (P=0.04) and increased resting coronary vascular resistance (CVR) by 15% (P=0.03). Glibenclamide reduced pacing-induced peak CBF (50.8+/-6.8 versus 42.0+/-5.4 mL/min, P=0.001), peak CBF corrected for baseline flow (25.1+/-4.6 versus 17.6+/-3.1 mL/min, P=0.01), and increased minimum CVR (2.6+/-0.3 versus 3.1+/-0.3 mm Hg/mL per minute, P=0.002). Compared with vehicle, glibenclamide reduced total AUC at 2 minutes (3535+/-397 versus 3027+/-326 mL, P=0.001).
Conclusions:
Vascular K(ATP) channels appear to be involved in functional coronary hyperemia after metabolic stimulation.
Related Concept Videos
Pathophysiology of Cardiac Performance
ATP Synthase: Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
G-Protein Gated Ion Channels
Sensory organs,...
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

